Clinical Trial Update: A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of voriconazole for fungal infections has completed. The study included candidiasis, cryptococcosis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidiasis
• Cryptococcosis

Drugs mentioned

• Voriconazole (Vfend) (voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Candidiasis, Cryptococcosis | Phase 4 | Status: COMPLETED